Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioCorRx Inc

BICX
Current price
0.31 USD 0 USD (0.00%)
Last closed 0.3 USD
ISIN US09073C2052
Sector Healthcare
Industry Medical Care Facilities
Exchange OTCQB
Capitalization 3 267 150 USD
Yield for 12 month -56.20 %
1Y
3Y
5Y
10Y
15Y
BICX
21.11.2021 - 28.11.2021

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program for substance abuse that includes peer recovery support; and distributes UnCraveRx weight loss management program, a medically assisted weight management program. The company is also developing BICX101, an injectable and implantable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California. Address: 2390 East Orangewood Avenue, Anaheim, CA, United States, 92806

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.1 USD

P/E ratio

Dividend Yield

Current Year

+89 160 USD

Last Year

+213 841 USD

Current Quarter

+4 045 USD

Last Quarter

+3 620 USD

Current Year

+53 174 USD

Last Year

+198 562 USD

Current Quarter

+4 045 USD

Last Quarter

+1 953 USD

Key Figures BICX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -4 095 768 USD
Operating Margin TTM -33852.95 %
PE Ratio
Return On Assets TTM -417.17 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 5.1 USD
Revenue TTM 36 748 USD
Book Value -1.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -79.4 %
Dividend Yield
Gross Profit TTM 42 391 USD
Earnings per share -0.48 USD
Diluted Eps TTM -0.48 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BICX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BICX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:100
Payout Ratio
Last Split Date 22.01.2019
Dividend Date 22.01.2019

Stock Valuation BICX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 147.9384
Price Sales TTM 88.9069
Enterprise Value EBITDA -4.1879
Price Book MRQ 209.3708

Financials BICX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BICX

For 52 weeks

0.28 USD 1.58 USD
50 Day MA 0.33 USD
Shares Short Prior Month
200 Day MA 0.64 USD
Short Ratio
Shares Short
Short Percent